These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15452755)

  • 21. Defining the "Health Benefit Basket" in nine European countries. Evidence from the European Union Health BASKET Project.
    Schreyögg J; Stargardt T; Velasco-Garrido M; Busse R
    Eur J Health Econ; 2005 Dec; Suppl(Suppl 1):2-10. PubMed ID: 16270212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.
    Turner HC; Archer RA; Downey LE; Isaranuwatchai W; Chalkidou K; Jit M; Teerawattananon Y
    Front Public Health; 2021; 9():722927. PubMed ID: 34513790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.
    Špacírová Z; Epstein D; Espín J
    Eur J Health Econ; 2022 Dec; 23(9):1563-1575. PubMed ID: 35217963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.
    Paradis PE; Latrémouille-Viau D; Moore Y; Mishagina N; Lafeuille MH; Lefebvre P; Gaudig M; Duh MS
    Curr Med Res Opin; 2009 Jul; 25(7):1793-805. PubMed ID: 19505202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polish activity within Orphanet Europe--state of art of database and services.
    Jezela-Stanek A; Karczmarewicz D; Chrzanowska KH; Krajewska-Walasek M
    Dev Period Med; 2015; 19(4):536-41. PubMed ID: 26982769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CIGNOweb.it.
    Truccolo I; Bogliolo A; Ricci R; Giacomini M; Pivetti S; Russell-Edu W; De Lorenzo F; Della Seta M; Colombo C; Bufalino R; Bocchini G; Pierotti M; Lombardo C; De Paoli P
    Tumori; 2011; 97(1):133-5. PubMed ID: 21528679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research on the Spatial Structure of the European Union's Tourism Economy and Its Effects.
    Xie W; Li H; Yin Y
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of formal benefit/cost evaluations in health system decision making.
    Bloom BS
    Am J Manag Care; 2004 May; 10(5):329-35. PubMed ID: 15152703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation databases as an aid to healthcare decision makers and researchers.
    Aguiar-Ibáñez R; Nixon J; Glanville J; Craig D; Rice S; Christie J; Drummond MF
    Expert Rev Pharmacoecon Outcomes Res; 2005 Dec; 5(6):721-32. PubMed ID: 19807614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relationship Between the Scope of Essential Health Benefits and Statutory Financing: An International Comparison Across Eight European Countries.
    van der Wees PJ; Wammes JJ; Westert GP; Jeurissen PP
    Int J Health Policy Manag; 2015 Sep; 5(1):13-22. PubMed ID: 26673645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is family planning effective and profitable in Rwanda?].
    Tallon F
    Imbonezamuryango; 1990 Aug; (18):22-7. PubMed ID: 12316570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based practice: the role of the NHS Centre for Reviews and Dissemination.
    Glanville J
    Health Libr Rev; 1994 Dec; 11(4):243-51. PubMed ID: 10141712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of EMBASE within the NHS: findings of the Database Access Project working partnership to extend the knowledge base of healthcare.
    Hallam E; Plaice C
    Health Libr Rev; 1999 Sep; 16(3):192-203. PubMed ID: 10620853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.
    Zwart-van Rijkom JE; Leufkens HG; Busschbach JJ; Broekmans AW; Rutten FF
    Pharmacoeconomics; 2000 Aug; 18(2):149-60. PubMed ID: 11067649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.